Filename Description liv70493-sup-0001-Supinfo.docxWord 2007 document , 323.1 KB Figure S1: Duration of response for nivolumab plus ipilimumab responders. Figure S2: Survival outcomes according to dosing regimen of nivolumab plus ipilimumab. Figure S3: Survival outcomes according to presence of immune-related thyroid dysfunction. Figure S4: Survival outcomes according to presence of immune-related adrenal insufficiency.